Brief: Race Oncology Gets Human Ethics Approval For Observational Cardioprotection Breast Cancer Trial
01/02/2023 01:24
Feb 1 (Reuters) - Race Oncology Ltd RAC.AX :
* RECEIVES HUMAN ETHICS APPROVAL FOR OBSERVATIONAL
CARDIOPROTECTION BREAST CANCER TRIAL
Source text for Eikon: ID:nASX1Cr6r
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220